Japanese pharmaceutical firm Daiichi Sankyo has named Glenn Gormley as President and Chairman of Daiichi Sankyo Inc in the US. Gormley will also continue in his current roles as President, Daiichi Sankyo Pharma Development, Global Head of Research and Development and Senior Executive Officer of Daiichi Sankyo Co Ltd.
In addition, Greg Barrett has been appointed as the new acting head of the Commercial Division of Daiichi Sankyo Inc, which is headquartered in Parsippany in the US.
Greg Barrett
Daiichi Sankyo Inc's former President and CEO and Head of its Commercial Division, John Gargiulo, has left the company.
Barrett has taken responsibility for leading the marketing, sales and supply chain operations in the US organisation. Most recently he was Vice President, Marketing and Managed Markets, at Daiichi Sankyo Inc and has been with the company since the late 1990s.
